Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes
(CREST Trial)
Recruiting at 15 trial locations
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Iantrek, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
This trial involves adults with open angle glaucoma who had surgery to lower eye pressure. The study will follow these patients for two years to collect data on eye pressure, medication use, and any side effects.
Research Team
GK
Gautam Kamthan, MD
Principal Investigator
Iantrek, Inc.
Eligibility Criteria
Inclusion Criteria
You have an intraocular pressure of less than 31 mmHg prior to surgery.
You have used ≤ 3 ocular hypotensive medications prior to surgery.
You have undergone an IOP-lowering surgical procedure using the CycloPen System.
Exclusion Criteria
You have a narrow angle in your eye.
Clinically significant corneal abnormality or concurrent intraocular pathology
Previous trabeculectomy or tube-shunt surgery, or previous iridotomy
See 1 more
Treatment Details
Interventions
- CycloPen Cyclodialysis System
Participant Groups
2Treatment groups
Experimental Treatment
Group I: CycloPen Cyclodialysis System in standalone surgeryExperimental Treatment1 Intervention
Ophthalmic surgical intervention with the CycloPen Cyclodialysis System
Group II: CycloPen Cyclodialysis System in conjunction with cataract surgeryExperimental Treatment1 Intervention
Ophthalmic surgical intervention with the CycloPen Cyclodialysis System in conjunction with cataract surgery
Find a Clinic Near You
Who Is Running the Clinical Trial?
Iantrek, Inc.
Lead Sponsor
Trials
2
Recruited
500+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.